Research location
Westminster
California, United States
Advertisement
Research activity in Westminster
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 70 trials and 71 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Westminster
70 linked trials · page 1 of 2Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaNCT06307665 · 2024-05-20 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseNCT06283966 · 2024-02-21 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078 · 2025-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)NCT06966479 · 2025-05-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaNCT06572228 · 2024-08-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With AsthmaNCT06502366 · 2024-07-22 · 1 site observation
COMPLETED
A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPDNCT06533553 · 2024-07-09 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaNCT06376045 · 2024-05-24 · 1 site observation
TERMINATED
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)NCT06196879 · 2024-02-27 · 1 site observation
COMPLETED
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsNCT06040086 · 2023-09-22 · 1 site observation
COMPLETED
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsNCT06052267 · 2023-08-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high AsthmaNCT05935332 · 2023-07-05 · 1 site observation
TERMINATED
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.NCT05763121 · 2023-01-30 · 1 site observation
TERMINATED
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic AsthmaNCT05748600 · 2023-01-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidNCT05292586 · 2022-08-31 · 1 site observation
COMPLETED
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe AsthmaNCT05421598 · 2022-06-30 · 1 site observation
COMPLETED
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United StatesNCT05329194 · 2022-04-29 · 1 site observation
COMPLETED
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDNCT04320342 · 2022-04-27 · 1 site observation
COMPLETED
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaNCT05097287 · 2021-12-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular PressureNCT05165290 · 2021-11-29 · 1 site observation
UNKNOWN
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseNCT05037929 · 2021-10-05 · 1 site observation
COMPLETED
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)NCT04636814 · 2021-07-12 · 1 site observation
TERMINATED
A Study to Test if TEV-53275 is Effective in Relieving AsthmaNCT04847674 · 2021-05-04 · 1 site observation
TERMINATED
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)NCT04609878 · 2020-12-15 · 1 site observation
COMPLETED
A Study to Test if TEV-48574 is Effective in Relieving AsthmaNCT04545385 · 2020-10-07 · 1 site observation
TERMINATED
A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With AsthmaNCT04203797 · 2020-07-16 · 1 site observation
COMPLETED
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationNCT04456673 · 2020-07-06 · 1 site observation
COMPLETED
The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe AsthmaNCT04400318 · 2020-06-20 · 1 site observation
COMPLETED
Registry of Asthma Patients Initiating DUPIXENT®NCT04287621 · 2020-03-02 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.NCT04019561 · 2019-09-23 · 1 site observation
COMPLETED
Dose-range Finding Efficacy and Safety Study for QBW251 in COPD PatientsNCT04072887 · 2019-09-12 · 1 site observation
COMPLETED
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsNCT04053634 · 2019-08-26 · 1 site observation
COMPLETED
Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic AsthmaNCT04046939 · 2019-08-15 · 1 site observation
COMPLETED
Tezepelumab COPD Exacerbation StudyNCT04039113 · 2019-07-30 · 1 site observation
COMPLETED
Tezepelumab Home Use StudyNCT03968978 · 2019-05-21 · 1 site observation
COMPLETED
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled AsthmaNCT03706079 · 2019-01-07 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With AsthmaNCT03769090 · 2018-12-13 · 1 site observation
COMPLETED
Systemic Corticosteroids Avoidance Study in Severe Asthma PatientsNCT03629249 · 2018-12-13 · 1 site observation
TERMINATED
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial HypertensionNCT03657095 · 2018-12-10 · 1 site observation
TERMINATED
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 StudyNCT03691662 · 2018-09-27 · 1 site observation
COMPLETED
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)NCT03546907 · 2018-07-16 · 1 site observation
COMPLETED
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03478696 · 2018-06-25 · 1 site observation
COMPLETED
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)NCT03373045 · 2018-02-27 · 1 site observation
COMPLETED
Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant AsthmaNCT03358147 · 2017-12-13 · 1 site observation
COMPLETED
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled AsthmaNCT03347279 · 2017-11-23 · 1 site observation
COMPLETED
Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device RobustnessNCT03137992 · 2017-11-21 · 1 site observation
COMPLETED
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic SubjectsNCT03084718 · 2017-07-28 · 1 site observation
COMPLETED
A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseNCT03084796 · 2017-07-28 · 1 site observation
COMPLETED
Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma TreatmentNCT03052517 · 2017-03-21 · 1 site observation
TERMINATED
Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic PatientsNCT03015259 · 2016-12-29 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.